NAV Price ()
—
Number of stocks
—
—
Risk Indicator
—
Start a savings plan or make a one-off investment
Invest now with an online broker
Learn moreAbout this fund
Fund objectives
- The Fund employs a passive management – or indexing – investment approach and seeks to track the performance of the FTSE Developed Europe Choice Index (the “Index”).
- The Index is a market-capitalisation-weighted index composed of large and mid-cap stocks of companies located in developed markets in Europe. Market-capitalisation is the value of a company's outstanding shares in the market and shows the size of a company.
- The Index is constructed from the FTSE Developed Europe Index (the “Parent Index”) which is then screened for certain environmental, social and governance (i.e. controversy-related) criteria.
- Through the screening out of stocks of companies from its portfolio based on the potentially detrimental impact of their conduct or products on society and / or the environment, the Fund promotes certain environmental characteristics and social characteristics relating to social norms and standards.
- The Fund attempts to: 1.Track the performance of Index by investing in all, or substantially all, of the constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy to avoid losses.
- The Index methodology excludes stocks of companies that the sponsor of the Index determines (a) to be engaged or involved in specific activities of the supply chain for, and / or (b) derive revenue (above a threshold specified by the Index provider) from, certain activities relating to the following activities: (a) Vice Products (i.e., adult entertainment, alcohol, gambling, tobacco, cannabis); (b) Non-Renewable Energy (i.e., nuclear power, and fossil fuels (including power generation from oil, gas, and thermal coal which includes: (i) companies that have greater than 50% ownership of companies that own proved or probable reserves in coal, oil or gas, (ii) oil and gas production and supporting services, (iii) coal extraction, production and supporting services, (iv) oil and gas and thermal coal power generation, (v) extraction of arctic oil and gas, and (vi) extraction of oil sands)); and (c) Weapons (chemical & biological weapons, cluster munitions, anti-personnel landmines, nuclear weapons, civilian firearms, and conventional military weapons).The Index provider defines what constitutes “involvement” in each activity. This may be based on percentage of revenue or any connection to a restricted activity regardless of the amount of revenue received, and will relate to specific parts of the supply chain.
- Company product and conduct involvement is monitored on a yearly basis by the Index provider and as new data is made available to the Index provider.
- For the full investment strategy please review the prospectus.
Fund facts
Share class inception
02 Sep 2014
Minimum initial investment
$1,000,000.00
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Strategy
Index
Asset Class
Equity
Domicile
Ireland
Dividend schedule
—
Legal entity
Vanguard Investment Series PLC
Tax status
Austria, Germany and Switzerland reporting
Benchmark
FTSE Developed Europe Choice Index
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at 30 Nov 2025
Beta
R²
Annualized Tracking Error
1 year
3 years
5 years
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 406 | 391 | 31 Oct 2025 |
| Median market capital | 67.6 B | 67.6 B | 30 Nov 2025 |
| 16.7 x | 16.7 x | 30 Nov 2025 | |
| 2.3 x | 2.3 x | 30 Nov 2025 | |
| 13.1% | 13.1% | 30 Nov 2025 | |
| 13.8% | 13.8% | 30 Nov 2025 | |
| Portfolio turnover rate | -16.3% | — | 30 Sep 2025 |
Market allocation
As at 31 Oct 2025
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 19.24% | 19.24% | 0.00% |
| Switzerland | Europe | 16.67% | 16.67% | 0.00% |
| Germany | Europe | 15.89% | 15.87% | 0.02% |
| France | Europe | 10.22% | 10.77% | -0.55% |
| Netherlands | Europe | 9.96% | 9.97% | -0.01% |
| Sweden | Europe | 6.30% | 6.30% | 0.00% |
| Spain | Europe | 5.55% | 5.55% | 0.00% |
| Italy | Europe | 5.39% | 5.39% | 0.00% |
| Denmark | Europe | 3.66% | 3.66% | 0.00% |
| Finland | Europe | 1.84% | 1.84% | 0.00% |
| Belgium | Europe | 1.74% | 1.74% | 0.00% |
| Norway | Europe | 0.84% | 0.84% | 0.00% |
| Ireland | Europe | 0.70% | 0.70% | 0.00% |
| Poland | Europe | 0.69% | 0.69% | 0.00% |
| Austria | Europe | 0.56% | 0.56% | 0.00% |
Holdings details
As at 30 Nov 2025
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 4.39846% | Technology | NL | $25,478,590.20 | 28,203 |
| AstraZeneca PLC | 2.95795% | Health Care | GB | $17,134,241.86 | 107,397 |
| Roche Holding AG | 2.86897% | Health Care | CH | $16,618,852.64 | 50,379 |
| Nestle SA | 2.68070% | Consumer Staples | CH | $15,528,264.64 | 181,263 |
| SAP SE | 2.65211% | Technology | DE | $15,362,627.20 | 73,664 |
| Novartis AG | 2.58970% | Health Care | CH | $15,001,128.28 | 133,796 |
| Siemens AG | 2.07348% | Industrials | DE | $12,010,863.00 | 52,610 |
| Allianz SE | 1.77897% | Financials | DE | $10,304,891.70 | 27,679 |
| Banco Santander SA | 1.69563% | Financials | ES | $9,822,120.17 | 1,062,655 |
| Novo Nordisk A/S | 1.67285% | Health Care | DK | $9,690,148.42 | 228,306 |
Prices and distribution
Prices
NAV Price (USD)
$197.19
Change
-$1.35-0.68% At closure 12 Dec 2025
NAV 52-week high
$198.54
At closure 15 Dec 2025
NAV 52-week low
$149.35
At closure 15 Dec 2025
NAV 52-week difference
$49.20
Change
+24.78% At closure 15 Dec 2025
Historical Prices
-
Inception date
02 Sep 2014
| Date | NAV (USD) |
|---|---|
| 12 Dec 2025 | $197.1893 |
| 11 Dec 2025 | $198.5430 |
| 10 Dec 2025 | $195.3427 |
| 09 Dec 2025 | $195.3817 |
| 08 Dec 2025 | $194.9479 |
| 05 Dec 2025 | $195.6327 |
| 04 Dec 2025 | $195.7270 |
| 03 Dec 2025 | $194.7309 |
| 02 Dec 2025 | $194.2811 |
| 01 Dec 2025 | $194.0603 |
Distribution history
Distribution frequency
—
Historical performance 30 Nov 2025
2.98%
All dividends are reinvested for the "Accumulation" shares.
Purchase information
Currency
Base currency: USD
Fund codes
- Bloomberg: VGSEIUS
- Citi: KO9C
- ISIN: IE00B4Z8LP80
- MEX ID: VIVAN4
- SEDOL: B4Z8LP8